Agala, Ponciana A.
HRN: 23-84-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/04/2023
10/12/2023
IV
600mg
QID
Cellulitis Right Leg
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes